Hunan Key Laboratory of Cancer Metabolism, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, 410078, China.
Cancer Research Institute and School of Basic Medicine, Central South University, Changsha, Hunan, 410078, China.
Mol Cancer. 2024 Nov 29;23(1):267. doi: 10.1186/s12943-024-02172-y.
Cell death is a fundamental part of life for metazoans. To maintain the balance between cell proliferation and metabolism of human bodies, a certain number of cells need to be removed regularly. Hence, the mechanisms of cell death have been preserved during the evolution of multicellular organisms. Tumorigenesis is closely related with exceptional inhibition of cell death. Mutations or defects in cell death-related genes block the elimination of abnormal cells and enhance the resistance of malignant cells to chemotherapy. Therefore, the investigation of cell death mechanisms enables the development of drugs that directly induce tumor cell death. In the guidelines updated by the Cell Death Nomenclature Committee (NCCD) in 2018, cell death was classified into 12 types according to morphological, biochemical and functional classification, including intrinsic apoptosis, extrinsic apoptosis, mitochondrial permeability transition (MPT)-driven necrosis, necroptosis, ferroptosis, pyroptosis, PARP-1 parthanatos, entotic cell death, NETotic cell death, lysosome-dependent cell death, autophagy-dependent cell death, immunogenic cell death, cellular senescence and mitotic catastrophe. The mechanistic relationships between epigenetic controls and cell death in cancer progression were previously unclear. In this review, we will summarize the mechanisms of cell death pathways and corresponding epigenetic regulations. Also, we will explore the extensive interactions between these pathways and discuss the mechanisms of cell death in epigenetics which bring benefits to tumor therapy.
细胞死亡是后生动物生命的基本组成部分。为了维持人体细胞增殖和代谢之间的平衡,需要定期清除一定数量的细胞。因此,在多细胞生物的进化过程中,细胞死亡的机制得到了保留。肿瘤发生与细胞死亡的异常抑制密切相关。细胞死亡相关基因的突变或缺陷会阻止异常细胞的清除,并增强恶性细胞对化疗的抵抗力。因此,研究细胞死亡机制可以开发出直接诱导肿瘤细胞死亡的药物。在 2018 年细胞死亡命名委员会 (NCCD) 更新的指南中,根据形态、生化和功能分类,将细胞死亡分为 12 种类型,包括内在凋亡、外在凋亡、线粒体通透性转换 (MPT) 驱动的坏死、坏死性凋亡、铁死亡、细胞焦亡、PARP-1 伴坏死、自噬依赖性细胞死亡、免疫原性细胞死亡、细胞衰老和有丝分裂灾难。在癌症进展中,表观遗传调控与细胞死亡之间的机制关系以前并不清楚。在这篇综述中,我们将总结细胞死亡途径的机制和相应的表观遗传调控。此外,我们将探讨这些途径之间的广泛相互作用,并讨论细胞死亡在肿瘤治疗中带来益处的表观遗传学机制。